4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-23-038409
Director acquired 249 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Molineaux Christopher P. Director | 2023-06-15 | Option exercise | +51 | $0.72 | $37 | 31,805 | D |
| Molineaux Christopher P. Director | 2023-06-15 | Option exercise | +198 | $1.52 | $301 | 32,003 | D |
| Derivatives | |||||||
| Molineaux Christopher P. Director | 2023-06-15 | Option exercise · Stock Option (right to buy) | −51 | 0 | D | ||
| Molineaux Christopher P. Director | 2023-06-15 | Option exercise · Stock Option (right to buy) | −198 | 0 | D | ||
Loading xslF345X04/doc4.xml…